30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Clarus IV-A, L.P.

Insider profile

Performance

Overall performance
1.5

Performance over holding periods
1.5
30 days 90 days 120 days
Average return -24% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Clarus IV-A, L.P.'s trades of Galera Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2019-11-14 2019-11-12 B Purchase
28,359 -17.5%
464.25
US$1,222,345
28,359 -17.5% 464.25 US$1,222,345
2019-11-14 2019-11-12 B Purchase
12,457 -27.2%
18.92
US$4,454,619
12,457 -27.2% 18.92 US$4,454,619
2019-11-14 2019-11-12 B Purchase
98,443 +22.0%
431.87
US$2,162,416
98,443 +22.0% 431.87 US$2,162,416
2019-11-14 2019-11-12 B Purchase
80,786 +17.5%
12.00
US$969,432
80,786 +17.5% 12.00 US$969,432